chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain upper, Anticoagulant therapy, Antimicrobial susceptibility test resistant, Asymptomatic COVID-19, Back pain
Clinical narrative: Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary.  Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA.    Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility.  He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Bacteraemia, Bladder catheterisation, Blood culture, Enterobacter test positive, Heart rate decreased
Clinical narrative: Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary.  Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA.    Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility.  He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypotension, Infection, Intensive care, Klebsiella test positive, Loss of consciousness
Clinical narrative: Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary.  Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA.    Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility.  He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pyelonephritis, Resuscitation, SARS-CoV-2 test positive, Septic shock, Stent placement
Clinical narrative: Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary.  Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA.    Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility.  He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Unresponsive to stimuli, Urinary tract obstruction, Urine analysis abnormal, Urosepsis, Vomiting
Clinical narrative: Provider summary "This is a 77 yo male, with PMH significant for Afib, DM2, CKD3, HFrEF (EF 35-40%), CAD, bilateral nephrolithiasis s/p multiple recent urological procedures with bilateral stent placements, who presented to hospital ED today for complaints of back and stomach pain. Earlier today, pt reportedely had a large emesis and lost consciousness following with reported faint to no pulse from SNF. He was transported to the ED via medic. EMS reported that pt was unresponsive upon arrival, but had spontaneous respirations. Dr. with urology was notified, and felt that bilateral stent exchange might be indicated, as stents were placed beginning of the month. While in the ED, he became increasingly hypotensive and required initiation of pressors. ICU was contacted for admission for further resuscitation prior to Urological intervention. In the ED, pt was alert and orientated. He agreed to continuation of pressor support and further OR procedures if necessary.  Of note, he is a DNR/DNI and has had multiple ICU and hospital admissions over the last few months related to urosepsis or urological procedure needs. His niece is POA.    Patient with a complicated urologic history, here with septic shock from multi-drug bacteremia/pyelonephritis, obstructive uropathy/infected stone. Initially it was MDR ESBL Klebsiella, and subsequently Enterobacter found in urine. Patient was treated with Invanz and course was extended to two additional weeks from date of last negative Bcx (6/27/22) for which he did receive a midline. He was started on a midodrine course from the CCU, but weaned off. He has a frequent history of urinary retention which is alleviated by straight catheterization per the recommendations of Urology. He underwent bilateral stent exchange while admitted and will follow up with urology for a R ESWL after discharge tentatively on 7/20/22. Hospitalization was prolonged several days due to incidental covid-19 positive test though patient was and remained asymptomatic, thus postponing both R ESWL and discharge back to facility.  He was advised to remain off of ASA, Plavix until after the procedure and off of Eliquis until follow up with Cardiology occurred. For this reason, he was kept on a heparin gtt while hospitalized due to chadsvasc of 8.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was administered the Pfizer vaccine after the Beyond Use Date of 5/10/2022.   The patient had no other adverse events.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Asthenia, Blood test, Brain natriuretic peptide, COVID-19
Clinical narrative: Chief Complaint: COVID-positive/shortness of breath Additional Medical History:  Patient is an 85-year-old male who resides at a local nursing facility.  Patient has a history of coronary disease with prior CABG, congestive heart failure, atrial fibrillation, COPD, hypertension, hypercholesterolemia.  Patient tested positive for COVID 10 days ago.  He presents to the emergency room today by EMS secondary to increasing shortness of breath and hypoxia.  Patient was noted to have an oxygen saturation in the low 80s this morning at the nursing home.  EMS was called and he was transported to the hospital.  Patient does state he has had worsening shortness of breath over the last 3 to 5 days.  He is even short of breath when he rests.  Patient states he has memory loss and has a difficult time remembering all of his symptoms or the onset.  He is unsure if he had the COVID-vaccine in the past. Associated Symptoms: cough, memory loss, shortness of breath, weakness Denies Symptoms: no anxiety/ no appetite changes/ no chest pain/ no chills/ no depression/ no diarrhea/ no dizziness/ no fatigue/ no fever/ no focal weakness/ no headache/ no injury/ no rash/ no seizure/ no sensory changes/ no sore throat/ no speech changes/ no URI symptoms/ no vomiting/ no wheezing
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Cough, Dyspnoea, Dyspnoea at rest, Electrocardiogram
Clinical narrative: Chief Complaint: COVID-positive/shortness of breath Additional Medical History:  Patient is an 85-year-old male who resides at a local nursing facility.  Patient has a history of coronary disease with prior CABG, congestive heart failure, atrial fibrillation, COPD, hypertension, hypercholesterolemia.  Patient tested positive for COVID 10 days ago.  He presents to the emergency room today by EMS secondary to increasing shortness of breath and hypoxia.  Patient was noted to have an oxygen saturation in the low 80s this morning at the nursing home.  EMS was called and he was transported to the hospital.  Patient does state he has had worsening shortness of breath over the last 3 to 5 days.  He is even short of breath when he rests.  Patient states he has memory loss and has a difficult time remembering all of his symptoms or the onset.  He is unsure if he had the COVID-vaccine in the past. Associated Symptoms: cough, memory loss, shortness of breath, weakness Denies Symptoms: no anxiety/ no appetite changes/ no chest pain/ no chills/ no depression/ no diarrhea/ no dizziness/ no fatigue/ no fever/ no focal weakness/ no headache/ no injury/ no rash/ no seizure/ no sensory changes/ no sore throat/ no speech changes/ no URI symptoms/ no vomiting/ no wheezing
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Hypoxia, Laboratory test, Lung infiltration, SARS-CoV-2 test positive
Clinical narrative: Chief Complaint: COVID-positive/shortness of breath Additional Medical History:  Patient is an 85-year-old male who resides at a local nursing facility.  Patient has a history of coronary disease with prior CABG, congestive heart failure, atrial fibrillation, COPD, hypertension, hypercholesterolemia.  Patient tested positive for COVID 10 days ago.  He presents to the emergency room today by EMS secondary to increasing shortness of breath and hypoxia.  Patient was noted to have an oxygen saturation in the low 80s this morning at the nursing home.  EMS was called and he was transported to the hospital.  Patient does state he has had worsening shortness of breath over the last 3 to 5 days.  He is even short of breath when he rests.  Patient states he has memory loss and has a difficult time remembering all of his symptoms or the onset.  He is unsure if he had the COVID-vaccine in the past. Associated Symptoms: cough, memory loss, shortness of breath, weakness Denies Symptoms: no anxiety/ no appetite changes/ no chest pain/ no chills/ no depression/ no diarrhea/ no dizziness/ no fatigue/ no fever/ no focal weakness/ no headache/ no injury/ no rash/ no seizure/ no sensory changes/ no sore throat/ no speech changes/ no URI symptoms/ no vomiting/ no wheezing
Age: 95.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Dehydration, Dyspnoea
Clinical narrative: Provider summary "96-yr old female with a past medical history significant for HFpEF and aortic valve stenosis who presented after a syncopal episode. The paitent was admitted and later found to be COVID(+). Echo was done while inpatient but not resulted prior to discharge. The patient was found to be mildly dehydrated and responded to 500cc bolus. Suspected the syncopal episode was secondary to dehydration as the patient had mild shortness of breath and states she felt weak but vitals were stable during hospitalization. CXR was notable for possible left-sided pneumonia but likely symptoms were secondary to COVID, antibiotics were discontinued without evidence of secondary bacterial infection. "
Age: 95.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, SARS-CoV-2 test positive, Syncope
Clinical narrative: Provider summary "96-yr old female with a past medical history significant for HFpEF and aortic valve stenosis who presented after a syncopal episode. The paitent was admitted and later found to be COVID(+). Echo was done while inpatient but not resulted prior to discharge. The patient was found to be mildly dehydrated and responded to 500cc bolus. Suspected the syncopal episode was secondary to dehydration as the patient had mild shortness of breath and states she felt weak but vitals were stable during hospitalization. CXR was notable for possible left-sided pneumonia but likely symptoms were secondary to COVID, antibiotics were discontinued without evidence of secondary bacterial infection. "
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, Dyspnoea, Lung opacity, Malaise
Clinical narrative: Provider summary "49-year-old female with past medical history significant for multiple sclerosis and tobacco abuse.  She presented to the emergency department on 06/21/2022 with a chief complaint of shortness of breath.  She had recently had COVID which initially had improved but then her symptoms came back.  On arrival she was diagnosed with pneumonia as well as possibly bronchitis.  She was started on antibiotics and steroids.  She did initially require supplemental oxygen but was weaned down to room air.  She had a CTA performed which was negative for pulmonary embolism but did show ground-glass opacities in the bilateral upper lobes which should be followed to resolution on an outpatient basis.  Notably, she has no formal diagnosis of chronic obstructive pulmonary disease so she should also get pulmonary function testing on discharge as well.  On day of discharge patient was in improved and stable condition.  She was ready to go home and was given strict return precautions to which she verbalized understanding.   Patient/daughter verbalized understanding and agreement to the above discharge plan. All questions were answered at time of discharge. "
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pneumonia, SARS-CoV-2 test positive
Clinical narrative: Provider summary "49-year-old female with past medical history significant for multiple sclerosis and tobacco abuse.  She presented to the emergency department on 06/21/2022 with a chief complaint of shortness of breath.  She had recently had COVID which initially had improved but then her symptoms came back.  On arrival she was diagnosed with pneumonia as well as possibly bronchitis.  She was started on antibiotics and steroids.  She did initially require supplemental oxygen but was weaned down to room air.  She had a CTA performed which was negative for pulmonary embolism but did show ground-glass opacities in the bilateral upper lobes which should be followed to resolution on an outpatient basis.  Notably, she has no formal diagnosis of chronic obstructive pulmonary disease so she should also get pulmonary function testing on discharge as well.  On day of discharge patient was in improved and stable condition.  She was ready to go home and was given strict return precautions to which she verbalized understanding.   Patient/daughter verbalized understanding and agreement to the above discharge plan. All questions were answered at time of discharge. "
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer vaccine was stored incorrectly, it was placed in the regular freezer instead of the sub-zero freezer. I contacted the mom of the parent and informed her of the situation. She will converse with her husband to see if they would like to re-vaccinate pt.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Bacterial infection, Body temperature increased, Chest X-ray, Cough, Dehydration
Clinical narrative: Patient received her vaccine Thursday morning, June 30, 2022, about 9:00 AM. She had a cold starting 5-6 days prior, just runny nose and cough. Within 20-30 minutes, she said she was tired and wanted to sleep. She was falling asleep in the car. She had a temperature of 100.5. An hour post vaccine, she was 101.9. I medicated her with TYLENOL. Three hours post vaccine, her fever broke. Fever started to spike again in the evening, to 102. Friday morning she woke up with 100.5. I medicated her with TYLENYOL and sent her to school. She was fine all day until the evening again. This fever went on and I called her pediatrician on Sunday. She said if fever more than 5 days, we will see her.  I took her in yesterday, she was lethargic and dehydrated. She started antibiotics last night and is fever free this morning. She clearly has a bacterial infection. We believe the vaccine activated her immune system.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Nasopharyngitis, Pyrexia, Rhinorrhoea
Clinical narrative: Patient received her vaccine Thursday morning, June 30, 2022, about 9:00 AM. She had a cold starting 5-6 days prior, just runny nose and cough. Within 20-30 minutes, she said she was tired and wanted to sleep. She was falling asleep in the car. She had a temperature of 100.5. An hour post vaccine, she was 101.9. I medicated her with TYLENOL. Three hours post vaccine, her fever broke. Fever started to spike again in the evening, to 102. Friday morning she woke up with 100.5. I medicated her with TYLENYOL and sent her to school. She was fine all day until the evening again. This fever went on and I called her pediatrician on Sunday. She said if fever more than 5 days, we will see her.  I took her in yesterday, she was lethargic and dehydrated. She started antibiotics last night and is fever free this morning. She clearly has a bacterial infection. We believe the vaccine activated her immune system.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Urine analysis
Clinical narrative: Patient received her vaccine Thursday morning, June 30, 2022, about 9:00 AM. She had a cold starting 5-6 days prior, just runny nose and cough. Within 20-30 minutes, she said she was tired and wanted to sleep. She was falling asleep in the car. She had a temperature of 100.5. An hour post vaccine, she was 101.9. I medicated her with TYLENOL. Three hours post vaccine, her fever broke. Fever started to spike again in the evening, to 102. Friday morning she woke up with 100.5. I medicated her with TYLENYOL and sent her to school. She was fine all day until the evening again. This fever went on and I called her pediatrician on Sunday. She said if fever more than 5 days, we will see her.  I took her in yesterday, she was lethargic and dehydrated. She started antibiotics last night and is fever free this morning. She clearly has a bacterial infection. We believe the vaccine activated her immune system.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID 19 on June 27,2022 after testing negative for five days after my husband tested positive
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Migraine
Clinical narrative: About 12 hours after my Moderna vaccination, I developed a Migraine, it was really early morning. When I get a migraine I get sick to my stomach and I take ondansetron (Zofran) for nausea and rizatriptan. The last headache in contrast to the previous 3 vaccinations, is my medications worked. The previous 3 vaccinations I also experienced migraines that were much worse and nothing worked to relieve it. I had a telehealth visit, it was a regularly scheduled visit and I spoke with my PCP about having a migraine. She told me that she had called Moderna previously (because of my previous 3 reactions) and said they hadn't included headaches or migraines in their studies but that she has gotten a lot of women who have developed migraines after Moderna vaccinations.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Exercise tolerance decreased, Heart rate increased
Clinical narrative: heart rate is elevated when exercising or doing any walking.  an easy walk of 3 miles per hour on the treadmill will now have my heart rate higher than normal by 30 to 40 beats or more.  doing anything other than a light workout has not been possible for the last 6 weeks.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer vaccine was stored incorrectly. It was placed in the regular freezer instead of the sub-zero freezer. Pt's mother is notified and will converse with her husband to see if they would like to have patient be revaccinated.
Age: 1.75
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Patient had hives on neck and arms on Thursday (6/30). Mother noticed hives around 5pm when she finished work. On Friday (7/1) hives were still present but not as red. By Saturday (7/2) hives covered entire truck and were raised. On Sunday (7/3) hives covered patients entire body (face, neck, truck, legs, feet) and patient was given Benadryl as advised by doctor. On Monday (7/4) hives covered patients entire body but were improving. On Tuesday (7/5) hives were mostly gone but still present on arms and trunk. On Wednesday (7/6) all hives were gone.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Epistaxis, Faeces discoloured
Clinical narrative: Pfizer Dose 1 1/11/21 (EL1284 Pfizer Dose 2 2/2/21 (EL1283) COVID Positive 1/27/22  1/27/22: Patient is a very pleasant 68-year-old female who is an ARNP for Oncology group, no significant past medical history apart from osteoarthritis for which she was started on meloxicam 2 weeks ago.  Fully vaccinated for COVID-19 presented to the emergency department with a complaint of worsening cough, shortness of breath related since Monday. Patient was having some fever, flu-like symptoms associated with cough and some shortness of breath, yesterday she had a positive at home COVID test.  Today she noticed epistaxis and petechiae and decided to come into the emergency department.  Patient is very pleasant, healthy individual, no recent illness, she was recently started on meloxicam due to osteoarthritis otherwise no issues.  No history of cancer, not on chemotherapy, no history of any blood disorder in the family, no recent use of antibiotics. Prior to Monday she has been in her usual state of health.   Upon exam patient was having  some epistaxis, she has diffuse petechiae, she also complained of black tarry stool.   In ED, platelet count 4 K, WBC 1.8 K, hemoglobin 11.9 grams/deciliter, ED provider discussed with Oncology who recommended starting IVIG and giving Decadron 20 mg x 1.  1/30/22: 68-year-old female no significant past medical history presented with cough, shortness of breath and flu-like symptoms, tested positive for COVID-19.  Patient had epistaxis, petechia and melena so presented to the emergency room and found to have severe pancytopenia with platelet count of 4000. Admitted for possible ITP, received IVIG , steroids and platelet transfusion. Epistaxis resolved, platelet count improved. Hematology to following on pending work and will call patient to arrange follow up and possibly bone marrow biopsy. patient deemed stable for discharge and discharged home.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Immunoglobulin therapy, Inappropriate schedule of product administration, Influenza like illness, Melaena
Clinical narrative: Pfizer Dose 1 1/11/21 (EL1284 Pfizer Dose 2 2/2/21 (EL1283) COVID Positive 1/27/22  1/27/22: Patient is a very pleasant 68-year-old female who is an ARNP for Oncology group, no significant past medical history apart from osteoarthritis for which she was started on meloxicam 2 weeks ago.  Fully vaccinated for COVID-19 presented to the emergency department with a complaint of worsening cough, shortness of breath related since Monday. Patient was having some fever, flu-like symptoms associated with cough and some shortness of breath, yesterday she had a positive at home COVID test.  Today she noticed epistaxis and petechiae and decided to come into the emergency department.  Patient is very pleasant, healthy individual, no recent illness, she was recently started on meloxicam due to osteoarthritis otherwise no issues.  No history of cancer, not on chemotherapy, no history of any blood disorder in the family, no recent use of antibiotics. Prior to Monday she has been in her usual state of health.   Upon exam patient was having  some epistaxis, she has diffuse petechiae, she also complained of black tarry stool.   In ED, platelet count 4 K, WBC 1.8 K, hemoglobin 11.9 grams/deciliter, ED provider discussed with Oncology who recommended starting IVIG and giving Decadron 20 mg x 1.  1/30/22: 68-year-old female no significant past medical history presented with cough, shortness of breath and flu-like symptoms, tested positive for COVID-19.  Patient had epistaxis, petechia and melena so presented to the emergency room and found to have severe pancytopenia with platelet count of 4000. Admitted for possible ITP, received IVIG , steroids and platelet transfusion. Epistaxis resolved, platelet count improved. Hematology to following on pending work and will call patient to arrange follow up and possibly bone marrow biopsy. patient deemed stable for discharge and discharged home.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pancytopenia, Petechiae, Platelet count decreased, Platelet transfusion, Pyrexia
Clinical narrative: Pfizer Dose 1 1/11/21 (EL1284 Pfizer Dose 2 2/2/21 (EL1283) COVID Positive 1/27/22  1/27/22: Patient is a very pleasant 68-year-old female who is an ARNP for Oncology group, no significant past medical history apart from osteoarthritis for which she was started on meloxicam 2 weeks ago.  Fully vaccinated for COVID-19 presented to the emergency department with a complaint of worsening cough, shortness of breath related since Monday. Patient was having some fever, flu-like symptoms associated with cough and some shortness of breath, yesterday she had a positive at home COVID test.  Today she noticed epistaxis and petechiae and decided to come into the emergency department.  Patient is very pleasant, healthy individual, no recent illness, she was recently started on meloxicam due to osteoarthritis otherwise no issues.  No history of cancer, not on chemotherapy, no history of any blood disorder in the family, no recent use of antibiotics. Prior to Monday she has been in her usual state of health.   Upon exam patient was having  some epistaxis, she has diffuse petechiae, she also complained of black tarry stool.   In ED, platelet count 4 K, WBC 1.8 K, hemoglobin 11.9 grams/deciliter, ED provider discussed with Oncology who recommended starting IVIG and giving Decadron 20 mg x 1.  1/30/22: 68-year-old female no significant past medical history presented with cough, shortness of breath and flu-like symptoms, tested positive for COVID-19.  Patient had epistaxis, petechia and melena so presented to the emergency room and found to have severe pancytopenia with platelet count of 4000. Admitted for possible ITP, received IVIG , steroids and platelet transfusion. Epistaxis resolved, platelet count improved. Hematology to following on pending work and will call patient to arrange follow up and possibly bone marrow biopsy. patient deemed stable for discharge and discharged home.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, White blood cell count decreased
Clinical narrative: Pfizer Dose 1 1/11/21 (EL1284 Pfizer Dose 2 2/2/21 (EL1283) COVID Positive 1/27/22  1/27/22: Patient is a very pleasant 68-year-old female who is an ARNP for Oncology group, no significant past medical history apart from osteoarthritis for which she was started on meloxicam 2 weeks ago.  Fully vaccinated for COVID-19 presented to the emergency department with a complaint of worsening cough, shortness of breath related since Monday. Patient was having some fever, flu-like symptoms associated with cough and some shortness of breath, yesterday she had a positive at home COVID test.  Today she noticed epistaxis and petechiae and decided to come into the emergency department.  Patient is very pleasant, healthy individual, no recent illness, she was recently started on meloxicam due to osteoarthritis otherwise no issues.  No history of cancer, not on chemotherapy, no history of any blood disorder in the family, no recent use of antibiotics. Prior to Monday she has been in her usual state of health.   Upon exam patient was having  some epistaxis, she has diffuse petechiae, she also complained of black tarry stool.   In ED, platelet count 4 K, WBC 1.8 K, hemoglobin 11.9 grams/deciliter, ED provider discussed with Oncology who recommended starting IVIG and giving Decadron 20 mg x 1.  1/30/22: 68-year-old female no significant past medical history presented with cough, shortness of breath and flu-like symptoms, tested positive for COVID-19.  Patient had epistaxis, petechia and melena so presented to the emergency room and found to have severe pancytopenia with platelet count of 4000. Admitted for possible ITP, received IVIG , steroids and platelet transfusion. Epistaxis resolved, platelet count improved. Hematology to following on pending work and will call patient to arrange follow up and possibly bone marrow biopsy. patient deemed stable for discharge and discharged home.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Pain in extremity, Respiratory tract congestion
Clinical narrative: I had a sore arm for 3 days after receiving my booster in addition to a mild headache that lasted until the next day. Months later, I started having a bronchial cough that wouldn't go away; the cough worsened and caused some congestion. I took an at-home rapid antigen COVID-19 test on 07/01/2022, but that one came back negative. However, the next morning, the cough became worse so I took another at-home test on 07/02/2022 that came back positive. I called my doctor who prescribed me PAXLOVID. That evening, I took my first dose and will finish my last of the 5-day treatment tomorrow. As of now with the medication, I have a slight cough and feeling better but not as great as I was before contracting COVID-19.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a sore arm for 3 days after receiving my booster in addition to a mild headache that lasted until the next day. Months later, I started having a bronchial cough that wouldn't go away; the cough worsened and caused some congestion. I took an at-home rapid antigen COVID-19 test on 07/01/2022, but that one came back negative. However, the next morning, the cough became worse so I took another at-home test on 07/02/2022 that came back positive. I called my doctor who prescribed me PAXLOVID. That evening, I took my first dose and will finish my last of the 5-day treatment tomorrow. As of now with the medication, I have a slight cough and feeling better but not as great as I was before contracting COVID-19.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Informed pt's mom that the Pfizer vaccine that pt received in April and May is invalid. Revaccination is not required. She states she will converse with her husband to see if they wish to re-vaccinate pt.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pt was hospitalized with Covid 19 Dose #1 Moderna given 3/12/2021 Lot # 031A21A
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Dyspnoea, Echocardiogram normal, Ejection fraction normal
Clinical narrative: Pfizer Dose 1 3/10/21 (013A21A) Pfizer Dose 2 4/12/21 (025B21A) COVID Positive 1/31/22  1/31/22: A 60-year-old female with past medical history of interstitial lung disease/idiopathic fibrosing alveolitis awaiting lung transplant, chronic hypersensitive on home oxygen 4 L by NC, hypertension, systemic sclerosis, recent COVID 19 infection December 2021 comes to ED complaining of worsening of shortness of breath.  Patient states that she recent had COVID-19 infection in December 2021, has been having progressive shortness of breath and she saw her pulmonologist last week and was started on levofloxacin on 01/27/2022.  In spite of using levofloxacin she does not feel better.  Having low-grade fevers.  Cough is productive with small amounts of mucoid sputum.  No chest pain.  No sick contacts. Whenever she walks around her oxygen saturation drops into 70s, while on 5 L O2.  A concentrator at home does not allow the oxygen to go up above 5 L.   In the ED her temp was 100.2° F. chest x-ray reported new airspace disease on top of chronic interstitial changes concerning for superimposed infectious process for worsening interstitial lung disease.  ED provider attempted to contact Transplant Department, but did not receive a call back. She contacted the doctor, and he recommended IV ceftazidime for Pseudomonas coverage and IV vancomycin.  2/7/22: The patient known to have advanced a she lung disease with chronic hypoxic respiratory failure oxygen dependent at home, history of COVID-19 pneumonitis, history of scleroderma on immunosuppressive therapy, presented to the hospital with worsen shortness of breath and cough, proBNP was elevated, chest x-ray show worsening bilateral infiltrate, COVID-19 PCR test came back positive.  The patient diagnosed with high likely reinfection COVID-19 pneumonitis with possible secondary bacterial infection and acute on chronic hypoxic respiratory failure that did not require ventilator.  The patient started on remdesivir and dexamethasone and she was on vancomycin and ceftazidime and supportive nebulizer treatment.  The pulmonologist consulted and recommend to continue this medication, patient was on IV diuretics with improvement in her shortness of breath and symptoms, echocardiogram did not show indirect signs of pulmonary hypertension and EF 55%. The patient undergoing extensive lung transplant workup at the Transplant Center.  The patient completed the oxygen walking test and she require 4 L of oxygen at rest and 8 L while ambulating, recommend high concentrated nasal cannula.  Okay to be discharged as pale the palm and follow-up with her pulmonologist and the lung transplant clinic.  Will discharge her on taper steroid, she completed her antibiotic regimen.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Hypertension, Inappropriate schedule of product administration, Interstitial lung disease, Lung disorder
Clinical narrative: Pfizer Dose 1 3/10/21 (013A21A) Pfizer Dose 2 4/12/21 (025B21A) COVID Positive 1/31/22  1/31/22: A 60-year-old female with past medical history of interstitial lung disease/idiopathic fibrosing alveolitis awaiting lung transplant, chronic hypersensitive on home oxygen 4 L by NC, hypertension, systemic sclerosis, recent COVID 19 infection December 2021 comes to ED complaining of worsening of shortness of breath.  Patient states that she recent had COVID-19 infection in December 2021, has been having progressive shortness of breath and she saw her pulmonologist last week and was started on levofloxacin on 01/27/2022.  In spite of using levofloxacin she does not feel better.  Having low-grade fevers.  Cough is productive with small amounts of mucoid sputum.  No chest pain.  No sick contacts. Whenever she walks around her oxygen saturation drops into 70s, while on 5 L O2.  A concentrator at home does not allow the oxygen to go up above 5 L.   In the ED her temp was 100.2° F. chest x-ray reported new airspace disease on top of chronic interstitial changes concerning for superimposed infectious process for worsening interstitial lung disease.  ED provider attempted to contact Transplant Department, but did not receive a call back. She contacted the doctor, and he recommended IV ceftazidime for Pseudomonas coverage and IV vancomycin.  2/7/22: The patient known to have advanced a she lung disease with chronic hypoxic respiratory failure oxygen dependent at home, history of COVID-19 pneumonitis, history of scleroderma on immunosuppressive therapy, presented to the hospital with worsen shortness of breath and cough, proBNP was elevated, chest x-ray show worsening bilateral infiltrate, COVID-19 PCR test came back positive.  The patient diagnosed with high likely reinfection COVID-19 pneumonitis with possible secondary bacterial infection and acute on chronic hypoxic respiratory failure that did not require ventilator.  The patient started on remdesivir and dexamethasone and she was on vancomycin and ceftazidime and supportive nebulizer treatment.  The pulmonologist consulted and recommend to continue this medication, patient was on IV diuretics with improvement in her shortness of breath and symptoms, echocardiogram did not show indirect signs of pulmonary hypertension and EF 55%. The patient undergoing extensive lung transplant workup at the Transplant Center.  The patient completed the oxygen walking test and she require 4 L of oxygen at rest and 8 L while ambulating, recommend high concentrated nasal cannula.  Okay to be discharged as pale the palm and follow-up with her pulmonologist and the lung transplant clinic.  Will discharge her on taper steroid, she completed her antibiotic regimen.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Oxygen saturation decreased, Polyuria, Productive cough, Prohormone brain natriuretic peptide increased
Clinical narrative: Pfizer Dose 1 3/10/21 (013A21A) Pfizer Dose 2 4/12/21 (025B21A) COVID Positive 1/31/22  1/31/22: A 60-year-old female with past medical history of interstitial lung disease/idiopathic fibrosing alveolitis awaiting lung transplant, chronic hypersensitive on home oxygen 4 L by NC, hypertension, systemic sclerosis, recent COVID 19 infection December 2021 comes to ED complaining of worsening of shortness of breath.  Patient states that she recent had COVID-19 infection in December 2021, has been having progressive shortness of breath and she saw her pulmonologist last week and was started on levofloxacin on 01/27/2022.  In spite of using levofloxacin she does not feel better.  Having low-grade fevers.  Cough is productive with small amounts of mucoid sputum.  No chest pain.  No sick contacts. Whenever she walks around her oxygen saturation drops into 70s, while on 5 L O2.  A concentrator at home does not allow the oxygen to go up above 5 L.   In the ED her temp was 100.2° F. chest x-ray reported new airspace disease on top of chronic interstitial changes concerning for superimposed infectious process for worsening interstitial lung disease.  ED provider attempted to contact Transplant Department, but did not receive a call back. She contacted the doctor, and he recommended IV ceftazidime for Pseudomonas coverage and IV vancomycin.  2/7/22: The patient known to have advanced a she lung disease with chronic hypoxic respiratory failure oxygen dependent at home, history of COVID-19 pneumonitis, history of scleroderma on immunosuppressive therapy, presented to the hospital with worsen shortness of breath and cough, proBNP was elevated, chest x-ray show worsening bilateral infiltrate, COVID-19 PCR test came back positive.  The patient diagnosed with high likely reinfection COVID-19 pneumonitis with possible secondary bacterial infection and acute on chronic hypoxic respiratory failure that did not require ventilator.  The patient started on remdesivir and dexamethasone and she was on vancomycin and ceftazidime and supportive nebulizer treatment.  The pulmonologist consulted and recommend to continue this medication, patient was on IV diuretics with improvement in her shortness of breath and symptoms, echocardiogram did not show indirect signs of pulmonary hypertension and EF 55%. The patient undergoing extensive lung transplant workup at the Transplant Center.  The patient completed the oxygen walking test and she require 4 L of oxygen at rest and 8 L while ambulating, recommend high concentrated nasal cannula.  Okay to be discharged as pale the palm and follow-up with her pulmonologist and the lung transplant clinic.  Will discharge her on taper steroid, she completed her antibiotic regimen.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory failure, SARS-CoV-2 test positive, Superinfection, Systemic scleroderma
Clinical narrative: Pfizer Dose 1 3/10/21 (013A21A) Pfizer Dose 2 4/12/21 (025B21A) COVID Positive 1/31/22  1/31/22: A 60-year-old female with past medical history of interstitial lung disease/idiopathic fibrosing alveolitis awaiting lung transplant, chronic hypersensitive on home oxygen 4 L by NC, hypertension, systemic sclerosis, recent COVID 19 infection December 2021 comes to ED complaining of worsening of shortness of breath.  Patient states that she recent had COVID-19 infection in December 2021, has been having progressive shortness of breath and she saw her pulmonologist last week and was started on levofloxacin on 01/27/2022.  In spite of using levofloxacin she does not feel better.  Having low-grade fevers.  Cough is productive with small amounts of mucoid sputum.  No chest pain.  No sick contacts. Whenever she walks around her oxygen saturation drops into 70s, while on 5 L O2.  A concentrator at home does not allow the oxygen to go up above 5 L.   In the ED her temp was 100.2° F. chest x-ray reported new airspace disease on top of chronic interstitial changes concerning for superimposed infectious process for worsening interstitial lung disease.  ED provider attempted to contact Transplant Department, but did not receive a call back. She contacted the doctor, and he recommended IV ceftazidime for Pseudomonas coverage and IV vancomycin.  2/7/22: The patient known to have advanced a she lung disease with chronic hypoxic respiratory failure oxygen dependent at home, history of COVID-19 pneumonitis, history of scleroderma on immunosuppressive therapy, presented to the hospital with worsen shortness of breath and cough, proBNP was elevated, chest x-ray show worsening bilateral infiltrate, COVID-19 PCR test came back positive.  The patient diagnosed with high likely reinfection COVID-19 pneumonitis with possible secondary bacterial infection and acute on chronic hypoxic respiratory failure that did not require ventilator.  The patient started on remdesivir and dexamethasone and she was on vancomycin and ceftazidime and supportive nebulizer treatment.  The pulmonologist consulted and recommend to continue this medication, patient was on IV diuretics with improvement in her shortness of breath and symptoms, echocardiogram did not show indirect signs of pulmonary hypertension and EF 55%. The patient undergoing extensive lung transplant workup at the Transplant Center.  The patient completed the oxygen walking test and she require 4 L of oxygen at rest and 8 L while ambulating, recommend high concentrated nasal cannula.  Okay to be discharged as pale the palm and follow-up with her pulmonologist and the lung transplant clinic.  Will discharge her on taper steroid, she completed her antibiotic regimen.